82925-02-8

Basic information

• Product Name: 4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE
• Synonyms: 4-[2-(6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-2-ISOQUINOLINYL)ETHYL]ANILINE;4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE;[4-[2-(6,7-DiMethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]aMine;BenzenaMine, 4-[2-(3,4-dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)ethyl]-;4-(2-(6,7-DiMethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)aniline;EOS-62095
• CAS NO: 82925-02-8
• Molecular Formula: C₁₉H₂₄N₂O₂
• Molecular Weight: 312.41
• Product Categories: Amines;Aromatics;Heterocycles
• Mol File: 82925-02-8.mol
• Article Data: 28

Chemical Properties

• Melting Point: 129 °C
• Boiling Point: 473.704 °C at 760 mmHg
• Flash Point: 240.288 °C
• Appearance: /
• Density: 1.132 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.592
• Storage Temp.: -20°C Freezer, Under inert atmosphere
• Solubility: Soluble in dichloromethane, ethyl acetate and methanol.
• PKA: 8.00±0.20(Predicted)
• CAS DataBase Reference: 4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE(82925-02-8)
• EPA Substance Registry System: 4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE(82925-02-8)

Safety Data

• Hazardous Substances Data: 82925-02-8(Hazardous Substances Data)

Usage

Chemical Properties

White Solid

Uses

Different sources of media describe the Uses of 82925-02-8 differently. You can refer to the following data:
1. It is an intermediate for the preparation of Elacridar.
2. Intermediate for the preparation of Elacridar

InChI:InChI=1/C19H24N2O2/c1-22-18-11-15-8-10-21(13-16(15)12-19(18)23-2)9-7-14-3-5-17(20)6-4-14/h3-6,11-12H,7-10,13,20H2,1-2H3

Upstream product

• 1018524-30-5 2-(4-Amino-phenyl)-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethanone 
• 82925-01-7 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-(4-nitrophenyl)ethyl]-isoquinoline 
• 100-27-6 2-(4-nitrophenyl)ethanol 
• 5339-26-4 (4-nitrophenyl)ethyl bromide 
• 104-03-0 4-nitrobenzeneacetic acid 
• 82924-82-1 1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-(4-nitro-phenyl)-ethanone 
• 50434-36-1 4-nitrophenylacetyl chloride 
• 2328-12-3 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline monohydrochloride 
• 120-20-7 2-(3,4-dimethoxyphenyl)-ethylamine 
• 1745-07-9 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 

Downstream Products

• 945893-19-6 tert-butyl-4-bromo-2-({4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinolin-2-yl)ethyl]phenyl}carbamoyl)phenylcarbamate 
• 1024592-54-8 N-{4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-4,5-dimethoxy-2-nitro-benzamide 
• 1024592-65-1 N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)nicotinamide 
• 1157878-97-1 (E)-3-(4,5-dimethoxy-2-nitrophenyl)-N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-acrylamide 
• 1024592-60-6 3-bromo-N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)benzamide 
• 1157879-04-3 1-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-3-(3-nitrophenyl)urea 
• 1157878-96-0 (E)-3-(4-chlorophenyl)-N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)acrylamide 
• 1157878-99-3 N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-2-(2-nitrophenoxy)acetamide 
• 1157878-95-9 (E)-N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-3-(2-nitrophenyl)acrylamide 
• 1157878-94-8 N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)cinnamamide 
• 1157879-02-1 1-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-3-(2-nitrophenyl)urea 
• 1157879-05-4 1-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-3-(4-nitrophenyl)urea 
• 1073765-64-6 N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)benzamide 
• 1024592-44-6 N-(4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl)-4-nitrobenzamide 

Relevant articles and documents

ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME

The present disclosure relates to compounds of Formula (I): and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for the treatment of disorders in which expression of P-glycoprotein and/or cytochrome P450 (e.g., CYP3A4) is modulated (e.g., cancers which have developed multi-drug resistance).

Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor

Many chemotherapeutics, such as paclitaxel, are administered intravenously as they suffer from poor oral bioavailability, partly because of efflux mechanism of P-glycoprotein in the intestinal epithelium. To date, no drug has been approved by the U.S. Foo

Dimethoxy tetrahydroisoquinoline substituted purine derivative as well as preparation method and application thereof in anti-tumor drugs

The invention belongs to the technical field of medicines, and particularly relates to a dimethoxy tetrahydroisoquinoline substituted purine derivative and a preparation method thereof. The dimethoxy tetrahydroisoquinoline substituted purine derivative ca